Details of the Drug

General Information of Drug (ID: DMT0NTL)

Drug Name
BI-695500
Synonyms Rituximab biosimilar
Indication
Disease Entry ICD 11 Status REF
Chronic lymphocytic leukaemia 2A82.0 Phase 3 [1]
Follicular lymphoma 2A80 Phase 3 [2]
Non-hodgkin lymphoma 2B33.5 Phase 3 [1]
Rheumatoid arthritis FA20 Phase 3 [3]
Solid tumour/cancer 2A00-2F9Z Clinical trial [1]
Diffuse large B-cell lymphoma 2A81 Application submitted [1]
⏷ Show the Full List of Indication(s)
Cross-matching ID
TTD ID
D0X3HV
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)